SULINNO Trademark

Trademark Overview


On Wednesday, September 23, 2020, a trademark application was filed for SULINNO with the United States Patent and Trademark Office. The USPTO has given the SULINNO trademark a serial number of 79304552. The federal status of this trademark filing is REGISTERED as of Tuesday, November 2, 2021. This trademark is owned by Innovent Biologics (Suzhou) Co., Ltd.. The SULINNO trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of cancer for human purposes; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; blood products, namely, blood plasma, blood for medical purposes; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer for medical purposes; biological tissue cultures for veterinary purposes; drugs for the treatment of cancer for medical purposes; diagnostic preparations for medical purposes; vaccines; injectable solutions for the treatment of anaphylactic reactions
sulinno

General Information


Serial Number79304552
Word MarkSULINNO
Filing DateWednesday, September 23, 2020
Status700 - REGISTERED
Status DateTuesday, November 2, 2021
Registration Number6541740
Registration DateTuesday, November 2, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements


Goods and ServicesMedicines for the treatment of cancer for human purposes; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; blood products, namely, blood plasma, blood for medical purposes; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer for medical purposes; biological tissue cultures for veterinary purposes; drugs for the treatment of cancer for medical purposes; diagnostic preparations for medical purposes; vaccines; injectable solutions for the treatment of anaphylactic reactions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, May 16, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 25, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 25, 2022FINAL DISPOSITION PROCESSED
Wednesday, February 2, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 2, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Sunday, August 15, 2021NOTIFICATION PROCESSED BY IB
Wednesday, July 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 28, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 29, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 8, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 8, 2021FINAL REFUSAL E-MAILED
Thursday, April 8, 2021FINAL REFUSAL WRITTEN
Friday, April 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 22, 2021REFUSAL PROCESSED BY IB
Wednesday, March 3, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 2, 2021REFUSAL PROCESSED BY MPU
Friday, February 26, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 25, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 23, 2021APPLICATION FILING RECEIPT MAILED
Friday, February 19, 2021ASSIGNED TO EXAMINER
Friday, February 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 18, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB